Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global SARS-CoV-2 IgG (RBD) ELISA Market Growth (Status and Outlook) 2022-2028

  • LP 4900031
  • 102 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of SARS-CoV-2 IgG (RBD) ELISA will have significant change from previous year. According to our (LP Information) latest study, the global SARS-CoV-2 IgG (RBD) ELISA market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global SARS-CoV-2 IgG (RBD) ELISA market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States SARS-CoV-2 IgG (RBD) ELISA market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global SARS-CoV-2 IgG (RBD) ELISA market, reaching US$ million by the year 2028. As for the Europe SARS-CoV-2 IgG (RBD) ELISA landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main SARS-CoV-2 IgG (RBD) ELISA players cover R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, and BD Biosciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of SARS-CoV-2 IgG (RBD) ELISA market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

ELISA Sets

ELISA Kits

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital

Clinic

Disease control and prevention system

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

R&D Systems

Thermo Fisher Scientific

Ortho Clinical Diagnostics

BD Biosciences

ZEUS Scientific

Bio-Rad Laboratories

ALPCO

Enzo Life Sciences

BioMérieux

LOEWE Biochemica

Shenzhen YHLO Biotech

LG

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size 2017-2028

2.1.2 SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 SARS-CoV-2 IgG (RBD) ELISA Segment by Type

2.2.1 ELISA Sets

2.2.2 ELISA Kits

2.3 SARS-CoV-2 IgG (RBD) ELISA Market Size by Type

2.3.1 SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)

2.4 SARS-CoV-2 IgG (RBD) ELISA Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Disease control and prevention system

2.5 SARS-CoV-2 IgG (RBD) ELISA Market Size by Application

2.5.1 SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)

3 SARS-CoV-2 IgG (RBD) ELISA Market Size by Player

3.1 SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Players

3.1.1 Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Players (2020-2022)

3.1.2 Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Players (2020-2022)

3.2 Global SARS-CoV-2 IgG (RBD) ELISA Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 SARS-CoV-2 IgG (RBD) ELISA by Regions

4.1 SARS-CoV-2 IgG (RBD) ELISA Market Size by Regions (2017-2022)

4.2 Americas SARS-CoV-2 IgG (RBD) ELISA Market Size Growth (2017-2022)

4.3 APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Growth (2017-2022)

4.4 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Growth (2017-2022)

4.5 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Growth (2017-2022)

5 Americas

5.1 Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022)

5.2 Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)

5.3 Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2017-2022)

6.2 APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)

6.3 APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe SARS-CoV-2 IgG (RBD) ELISA by Country (2017-2022)

7.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)

7.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA by Region (2017-2022)

8.2 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)

8.3 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.1 Global SARS-CoV-2 IgG (RBD) ELISA Forecast by Regions (2023-2028)

10.1.1 Global SARS-CoV-2 IgG (RBD) ELISA Forecast by Regions (2023-2028)

10.1.2 Americas SARS-CoV-2 IgG (RBD) ELISA Forecast

10.1.3 APAC SARS-CoV-2 IgG (RBD) ELISA Forecast

10.1.4 Europe SARS-CoV-2 IgG (RBD) ELISA Forecast

10.1.5 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Forecast

10.2 Americas SARS-CoV-2 IgG (RBD) ELISA Forecast by Country (2023-2028)

10.2.1 United States SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.2.2 Canada SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.2.3 Mexico SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.2.4 Brazil SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.3 APAC SARS-CoV-2 IgG (RBD) ELISA Forecast by Region (2023-2028)

10.3.1 China SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.3.2 Japan SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.3.3 Korea SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.3.4 Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.3.5 India SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.3.6 Australia SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.4 Europe SARS-CoV-2 IgG (RBD) ELISA Forecast by Country (2023-2028)

10.4.1 Germany SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.4.2 France SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.4.3 UK SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.4.4 Italy SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.4.5 Russia SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.5 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Forecast by Region (2023-2028)

10.5.1 Egypt SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.5.2 South Africa SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.5.3 Israel SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.5.4 Turkey SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.5.5 GCC Countries SARS-CoV-2 IgG (RBD) ELISA Market Forecast

10.6 Global SARS-CoV-2 IgG (RBD) ELISA Forecast by Type (2023-2028)

10.7 Global SARS-CoV-2 IgG (RBD) ELISA Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 R&D Systems

11.1.1 R&D Systems Company Information

11.1.2 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.1.3 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 R&D Systems Main Business Overview

11.1.5 R&D Systems Latest Developments

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Information

11.2.2 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.2.3 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Thermo Fisher Scientific Main Business Overview

11.2.5 Thermo Fisher Scientific Latest Developments

11.3 Ortho Clinical Diagnostics

11.3.1 Ortho Clinical Diagnostics Company Information

11.3.2 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.3.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Ortho Clinical Diagnostics Main Business Overview

11.3.5 Ortho Clinical Diagnostics Latest Developments

11.4 BD Biosciences

11.4.1 BD Biosciences Company Information

11.4.2 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.4.3 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 BD Biosciences Main Business Overview

11.4.5 BD Biosciences Latest Developments

11.5 ZEUS Scientific

11.5.1 ZEUS Scientific Company Information

11.5.2 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.5.3 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 ZEUS Scientific Main Business Overview

11.5.5 ZEUS Scientific Latest Developments

11.6 Bio-Rad Laboratories

11.6.1 Bio-Rad Laboratories Company Information

11.6.2 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.6.3 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Bio-Rad Laboratories Main Business Overview

11.6.5 Bio-Rad Laboratories Latest Developments

11.7 ALPCO

11.7.1 ALPCO Company Information

11.7.2 ALPCO SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.7.3 ALPCO SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 ALPCO Main Business Overview

11.7.5 ALPCO Latest Developments

11.8 Enzo Life Sciences

11.8.1 Enzo Life Sciences Company Information

11.8.2 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.8.3 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Enzo Life Sciences Main Business Overview

11.8.5 Enzo Life Sciences Latest Developments

11.9 BioMérieux

11.9.1 BioMérieux Company Information

11.9.2 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.9.3 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 BioMérieux Main Business Overview

11.9.5 BioMérieux Latest Developments

11.10 LOEWE Biochemica

11.10.1 LOEWE Biochemica Company Information

11.10.2 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.10.3 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 LOEWE Biochemica Main Business Overview

11.10.5 LOEWE Biochemica Latest Developments

11.11 Shenzhen YHLO Biotech

11.11.1 Shenzhen YHLO Biotech Company Information

11.11.2 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.11.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Shenzhen YHLO Biotech Main Business Overview

11.11.5 Shenzhen YHLO Biotech Latest Developments

11.12 LG

11.12.1 LG Company Information

11.12.2 LG SARS-CoV-2 IgG (RBD) ELISA Product Offered

11.12.3 LG SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 LG Main Business Overview

11.12.5 LG Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of ELISA Sets

Table 3. Major Players of ELISA Kits

Table 4. SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)

Table 7. SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)

Table 10. Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Player (2020-2022)

Table 12. SARS-CoV-2 IgG (RBD) ELISA Key Players Head office and Products Offered

Table 13. SARS-CoV-2 IgG (RBD) ELISA Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Regions (2017-2022)

Table 18. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Country (2017-2022)

Table 20. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)

Table 22. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)

Table 24. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Region (2017-2022)

Table 26. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)

Table 28. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)

Table 30. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Country (2017-2022)

Table 32. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)

Table 34. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of SARS-CoV-2 IgG (RBD) ELISA

Table 43. Key Market Challenges & Risks of SARS-CoV-2 IgG (RBD) ELISA

Table 44. Key Industry Trends of SARS-CoV-2 IgG (RBD) ELISA

Table 45. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share Forecast by Application (2023-2028)

Table 51. R&D Systems Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 52. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 53. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. R&D Systems Main Business

Table 55. R&D Systems Latest Developments

Table 56. Thermo Fisher Scientific Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 57. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 58. Thermo Fisher Scientific Main Business

Table 59. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Thermo Fisher Scientific Latest Developments

Table 61. Ortho Clinical Diagnostics Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 62. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 63. Ortho Clinical Diagnostics Main Business

Table 64. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Ortho Clinical Diagnostics Latest Developments

Table 66. BD Biosciences Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 67. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 68. BD Biosciences Main Business

Table 69. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. BD Biosciences Latest Developments

Table 71. ZEUS Scientific Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 72. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 73. ZEUS Scientific Main Business

Table 74. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. ZEUS Scientific Latest Developments

Table 76. Bio-Rad Laboratories Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 77. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 78. Bio-Rad Laboratories Main Business

Table 79. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Bio-Rad Laboratories Latest Developments

Table 81. ALPCO Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 82. ALPCO SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 83. ALPCO Main Business

Table 84. ALPCO SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. ALPCO Latest Developments

Table 86. Enzo Life Sciences Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 87. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 88. Enzo Life Sciences Main Business

Table 89. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Enzo Life Sciences Latest Developments

Table 91. BioMérieux Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 92. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 93. BioMérieux Main Business

Table 94. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. BioMérieux Latest Developments

Table 96. LOEWE Biochemica Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 97. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 98. LOEWE Biochemica Main Business

Table 99. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. LOEWE Biochemica Latest Developments

Table 101. Shenzhen YHLO Biotech Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 102. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 103. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Shenzhen YHLO Biotech Main Business

Table 105. Shenzhen YHLO Biotech Latest Developments

Table 106. LG Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors

Table 107. LG SARS-CoV-2 IgG (RBD) ELISA Product Offered

Table 108. LG Main Business

Table 109. LG SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. LG Latest Developments

List of Figures

Figure 1. SARS-CoV-2 IgG (RBD) ELISA Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type in 2021

Figure 7. SARS-CoV-2 IgG (RBD) ELISA in Hospital

Figure 8. Global SARS-CoV-2 IgG (RBD) ELISA Market: Hospital (2017-2022) & ($ Millions)

Figure 9. SARS-CoV-2 IgG (RBD) ELISA in Clinic

Figure 10. Global SARS-CoV-2 IgG (RBD) ELISA Market: Clinic (2017-2022) & ($ Millions)

Figure 11. SARS-CoV-2 IgG (RBD) ELISA in Disease control and prevention system

Figure 12. Global SARS-CoV-2 IgG (RBD) ELISA Market: Disease control and prevention system (2017-2022) & ($ Millions)

Figure 13. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application in 2021

Figure 14. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Player in 2021

Figure 15. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Regions (2017-2022)

Figure 16. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size 2017-2022 ($ Millions)

Figure 17. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size 2017-2022 ($ Millions)

Figure 18. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size 2017-2022 ($ Millions)

Figure 20. Americas SARS-CoV-2 IgG (RBD) ELISA Value Market Share by Country in 2021

Figure 21. Americas SARS-CoV-2 IgG (RBD) ELISA Consumption Market Share by Type in 2021

Figure 22. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application in 2021

Figure 23. United States SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Region in 2021

Figure 28. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application in 2021

Figure 29. China SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 33. India SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Country in 2021

Figure 36. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type in 2021

Figure 37. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application in 2021

Figure 38. Germany SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 39. France SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application in 2021

Figure 46. Egypt SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 52. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 53. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 55. United States SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 56. Canada SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 57. Mexico SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 58. Brazil SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 59. China SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 60. Japan SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 61. Korea SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 63. India SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 64. Australia SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 65. Germany SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 66. France SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 67. UK SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 68. Italy SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 69. Russia SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 70. Spain SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 71. Egypt SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 72. South Africa SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 73. Israel SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 74. Turkey SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390